Literature DB >> 31300426

Approach to Ménière disease management.

Vincent Wu1, Edward A Sykes2, Michael M Beyea3, Matthew T W Simpson4, Jason A Beyea5.   

Abstract

OBJECTIVE: To provide family physicians with an updated approach to the diagnosis and management of Ménière disease (MD), detailing the natural course of MD and describing how to initiate medical therapy while awaiting consultation with otolaryngology-head and neck surgery. SOURCES OF INFORMATION: The approach is based on the authors' clinical practices and review articles from 1989 to 2018. Most of the cited studies provided level II or III evidence. MAIN MESSAGE: Ménière disease is an uncommon disorder of the inner ear causing vertigo attacks with associated unilateral hearing loss, tinnitus, and aural fullness. It has a degenerative course that often results in permanent sensorineural hearing loss. On average, MD stabilizes with no further vestibular attacks by about 8 years after the onset of symptoms; however, this is highly variable. Vertigo symptoms can be controlled through a combination of dietary salt restriction, stress reduction, and medical therapy (betahistine, diuretics, or both). These can be initiated by family physicians before consultation with otolaryngology-head and neck surgery. Symptoms refractory to such strategies can be treated using nonablative, and occasionally ablative, therapies.
CONCLUSION: A thorough history is key to the approach to and management of MD and permits differentiating MD from other vestibular and nonvestibular conditions. Copyright© the College of Family Physicians of Canada.

Entities:  

Year:  2019        PMID: 31300426      PMCID: PMC6738466     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  48 in total

1.  Oral administration of prednisone to control refractory vertigo in Ménière's disease: a pilot study.

Authors:  Elizabeth Morales-Luckie; Arnulfo Cornejo-Suarez; Miguel A Zaragoza-Contreras; Oscar Gonzalez-Perez
Journal:  Otol Neurotol       Date:  2005-09       Impact factor: 2.311

Review 2.  Initial evaluation of vertigo.

Authors:  Ronald H Labuguen
Journal:  Am Fam Physician       Date:  2006-01-15       Impact factor: 3.292

3.  Prevalence of Menière's disease in general population of Southern Finland.

Authors:  Mari Havia; Erna Kentala; Ilmari Pyykkö
Journal:  Otolaryngol Head Neck Surg       Date:  2005-11       Impact factor: 3.497

4.  Magnetic resonance imaging in patients with sudden hearing loss, tinnitus and vertigo.

Authors:  B Schick; D Brors; O Koch; M Schäfers; G Kahle
Journal:  Otol Neurotol       Date:  2001-11       Impact factor: 2.311

Review 5.  Ramsay Hunt syndrome: pathophysiology of cochleovestibular symptoms.

Authors:  R Kuhweide; V Van de Steene; S Vlaminck; J W Casselman
Journal:  J Laryngol Otol       Date:  2002-10       Impact factor: 1.469

Review 6.  The dizzy patient.

Authors:  R W Baloh
Journal:  Postgrad Med       Date:  1999-02       Impact factor: 3.840

Review 7.  Diagnosis and management of benign paroxysmal positional vertigo (BPPV).

Authors:  Lorne S Parnes; Sumit K Agrawal; Jason Atlas
Journal:  CMAJ       Date:  2003-09-30       Impact factor: 8.262

Review 8.  Diagnostic approach to tinnitus.

Authors:  Richard W Crummer; Ghinwa A Hassan
Journal:  Am Fam Physician       Date:  2004-01-01       Impact factor: 3.292

Review 9.  Diuretics for Ménière's disease or syndrome.

Authors:  A S Thirlwall; S Kundu
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

10.  Endolymphatic mastoid shunt: a reevaluation of efficacy.

Authors:  D B Welling; H N Nagaraja
Journal:  Otolaryngol Head Neck Surg       Date:  2000-03       Impact factor: 5.591

View more
  3 in total

1. 

Authors:  Daniel Newsted; Emily Rosen; Bonnie Cooke; Michael M Beyea; Matthew T W Simpson; Jason A Beyea
Journal:  Can Fam Physician       Date:  2020-11       Impact factor: 3.275

Review 2.  Approach to hearing loss.

Authors:  Daniel Newsted; Emily Rosen; Bonnie Cooke; Michael M Beyea; Matthew T W Simpson; Jason A Beyea
Journal:  Can Fam Physician       Date:  2020-11       Impact factor: 3.275

3.  Clinical application of cVEMPs and oVEMPs in patients affected by Ménière's disease, vestibular neuritis and benign paroxysmal positional vertigo: a systematic review.

Authors:  A Scarpa; F M Gioacchini; E Cassandro; M Tulli; M Ralli; M Re; C Cassandro
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-10       Impact factor: 2.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.